Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 62 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8853217

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  2. US 8853228

    Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  3. US 8846908

    Tricyclic carbamate JAK inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  4. US 8846917

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  5. US 8846913

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  6. US 8846918

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  7. US 8846713

    Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  8. US 8846684

    Arbovirus inhibitors and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  9. US 8846686

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  10. US 8841449

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  11. US 8841483

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  12. US 8841450

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  13. US 8841337

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  14. US 8841308

    Pyrazin-2-amines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  15. US 8841288

    Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases

    UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  16. US 8841295

    5-lipoxygenase-activating protein (FLAP) inhibitors

    Panmira Pharmaceuticals, LLC · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  17. US 8841257

    Inhibitors of STAT3 and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  18. US 8829187

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  19. US 8829007

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  20. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  21. US 8822681

    Azaindoles useful as inhibitors of janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  22. US 8822700

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  23. US 8822698

    Aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the Met family

    Oreste Piccolo Studio di Consulenza Scientifica · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  24. US 8822469

    Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted